Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is opening an independent primary
care practice in a state that grants full practice authority. Before
prescribing controlled substances, which action is most appropriate to
ensure compliance with U.S. federal requirements?
A. Obtain a National Provider Identifier (NPI) only
B. Obtain a Drug Enforcement Administration (DEA) registration after
meeting applicable state requirements
C. Collaborate with a physician to prescribe all Schedule II medications
D. Register with Medicare before prescribing any medication
Correct Answer: B
Rationale: APRNs who prescribe controlled substances must comply
with both state law and federal regulations, including obtaining a DEA
registration when authorized by state law. An NPI alone does not
authorize controlled substance prescribing. Physician collaboration is
not universally required in states with full practice authority. Medicare
enrollment is unrelated to prescribing authority.
Question 2
A newly certified APRN evaluates a patient requesting antibiotics for
symptoms consistent with a viral upper respiratory infection. Which
response best reflects evidence-based prescribing principles?
A. Prescribe a broad-spectrum antibiotic to prevent bacterial
superinfection.
,B. Delay treatment until bacterial resistance testing is available.
C. Explain why antibiotics are not indicated and recommend
symptomatic management with appropriate follow-up.
D. Prescribe antibiotics because patient satisfaction is an important
quality metric.
Correct Answer: C
Rationale: Responsible antimicrobial stewardship requires avoiding
unnecessary antibiotic use. Viral illnesses generally do not benefit from
antibiotics, and unnecessary prescribing contributes to antimicrobial
resistance and adverse drug events. Broad-spectrum antibiotics
increase resistance and adverse effects without benefit. Resistance
testing is not indicated for uncomplicated viral infections, and patient
satisfaction should never supersede evidence-based care.
Question 3
An APRN is prescribing a medication with potential nephrotoxicity for
an older adult with chronic kidney disease. Which factor should be
assessed before selecting the initial dose?
A. Patient's preferred pharmacy
B. Estimated renal function
C. Insurance formulary status only
D. Family history of hypertension
Correct Answer: B
Rationale: Renal function is a major determinant of medication
clearance for many drugs. Estimating kidney function helps determine
, whether dose adjustment or an alternative medication is necessary.
Although insurance and pharmacy considerations affect access, they do
not determine safe dosing. Family history is less relevant than the
patient's current renal function.
Question 4
An APRN prescribes a medication associated with significant fetal risk. A
reproductive-age patient reports being sexually active and not using
contraception. What is the most appropriate next step?
A. Initiate therapy without further discussion.
B. Recommend discontinuing sexual activity.
C. Discuss pregnancy potential, contraceptive options, and medication
risks before prescribing.
D. Require sterilization before treatment.
Correct Answer: C
Rationale: Safe prescribing includes assessing pregnancy potential,
discussing teratogenic risks, and counseling regarding effective
contraception when appropriate. Therapy should not begin without
informed discussion. Sterilization is neither appropriate nor ethical, and
abstinence should not be assumed as the sole risk-reduction strategy.
Question 5
An APRN is considering a newly approved medication that is
substantially more expensive than established therapy. Which
prescribing approach best reflects evidence-based practice?
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is opening an independent primary
care practice in a state that grants full practice authority. Before
prescribing controlled substances, which action is most appropriate to
ensure compliance with U.S. federal requirements?
A. Obtain a National Provider Identifier (NPI) only
B. Obtain a Drug Enforcement Administration (DEA) registration after
meeting applicable state requirements
C. Collaborate with a physician to prescribe all Schedule II medications
D. Register with Medicare before prescribing any medication
Correct Answer: B
Rationale: APRNs who prescribe controlled substances must comply
with both state law and federal regulations, including obtaining a DEA
registration when authorized by state law. An NPI alone does not
authorize controlled substance prescribing. Physician collaboration is
not universally required in states with full practice authority. Medicare
enrollment is unrelated to prescribing authority.
Question 2
A newly certified APRN evaluates a patient requesting antibiotics for
symptoms consistent with a viral upper respiratory infection. Which
response best reflects evidence-based prescribing principles?
A. Prescribe a broad-spectrum antibiotic to prevent bacterial
superinfection.
,B. Delay treatment until bacterial resistance testing is available.
C. Explain why antibiotics are not indicated and recommend
symptomatic management with appropriate follow-up.
D. Prescribe antibiotics because patient satisfaction is an important
quality metric.
Correct Answer: C
Rationale: Responsible antimicrobial stewardship requires avoiding
unnecessary antibiotic use. Viral illnesses generally do not benefit from
antibiotics, and unnecessary prescribing contributes to antimicrobial
resistance and adverse drug events. Broad-spectrum antibiotics
increase resistance and adverse effects without benefit. Resistance
testing is not indicated for uncomplicated viral infections, and patient
satisfaction should never supersede evidence-based care.
Question 3
An APRN is prescribing a medication with potential nephrotoxicity for
an older adult with chronic kidney disease. Which factor should be
assessed before selecting the initial dose?
A. Patient's preferred pharmacy
B. Estimated renal function
C. Insurance formulary status only
D. Family history of hypertension
Correct Answer: B
Rationale: Renal function is a major determinant of medication
clearance for many drugs. Estimating kidney function helps determine
, whether dose adjustment or an alternative medication is necessary.
Although insurance and pharmacy considerations affect access, they do
not determine safe dosing. Family history is less relevant than the
patient's current renal function.
Question 4
An APRN prescribes a medication associated with significant fetal risk. A
reproductive-age patient reports being sexually active and not using
contraception. What is the most appropriate next step?
A. Initiate therapy without further discussion.
B. Recommend discontinuing sexual activity.
C. Discuss pregnancy potential, contraceptive options, and medication
risks before prescribing.
D. Require sterilization before treatment.
Correct Answer: C
Rationale: Safe prescribing includes assessing pregnancy potential,
discussing teratogenic risks, and counseling regarding effective
contraception when appropriate. Therapy should not begin without
informed discussion. Sterilization is neither appropriate nor ethical, and
abstinence should not be assumed as the sole risk-reduction strategy.
Question 5
An APRN is considering a newly approved medication that is
substantially more expensive than established therapy. Which
prescribing approach best reflects evidence-based practice?
